Skip to main content
Caplight Logo









Tidetron Bioworks

Tidetron Bioworks

Private
GuangzhouHealthcare & Life Scienceshttps://tidetronpeptide.com

Last Round

Series A

Extension

Mar 14, 2022

Total Funding Raised

$100M

Company Overview

Tidetron Bioworks is a synthetic biology company that develops and operates a biomanufacturing platform for the mass production of sustainable materials for the biomedical, cosmetics, and food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Fashion & Beauty, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

synthetic peptidesCDMOcontract development and manufacturing organizationbio-based chemicalssynthetic biologyfermentation technologycosmetic peptidesactive pharmaceutical ingredientsAPIstrain engineeringbiomanufacturingcustom synthesispeptide discoveryOEM manufacturingsynbio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tidetron Bioworks Comparables

Compare Tidetron Bioworks with similar companies based on industry and business-model similarity.

Tidetron Bioworks comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Abiochem Biotechnology
77%
Bota Biosciences
76%
弈柯莱生物科技(集团)股份有限公司
73%

Tidetron Bioworks Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 14, 2022
AngelMay 1, 2021
Series AMay 1, 2021

Tidetron Bioworks Investors

Notable investors and investment history

Tidetron Bioworks investors
InvestorRounds
IDG CapitalAngel, Series A, Series A Extension
ZhenFundAngel, Series A
Legend CapitalSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2021

    Raised Series A with IDG Capital and ZhenFund.

  • May 1, 2021

    Raised an Angel round with IDG Capital and ZhenFund.

Tidetron Bioworks Filings

Explore SEC and related filing metadata, where available.

Tidetron Bioworks filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tidetron Bioworks's valuation, stock price, and market status.

Is Tidetron Bioworks a public or private company?

Tidetron Bioworks is a private company.

What is the current stock price of Tidetron Bioworks?

Tidetron Bioworks is a private company with no public stock price. No recent secondary market data is available.

How much is Tidetron Bioworks worth (valuation)?

Valuation information for Tidetron Bioworks is not publicly available.

Can I buy Tidetron Bioworks stock?

Tidetron Bioworks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Tidetron Bioworks's last funding round?

Tidetron Bioworks's most recent funding round was Series A Extension on March 14, 2022.

Who are the main investors in Tidetron Bioworks?

Key investors in Tidetron Bioworks include IDG Capital.

Will Tidetron Bioworks IPO soon?

No public IPO plans have been announced for Tidetron Bioworks.

How can I track Tidetron Bioworks secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tidetron Bioworks's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGuangzhou
Year Founded2021
Last FundingMar 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?